CEBP Grants Frontiers in Basic Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Epidemiology Biomarkers & Prevention 16, 1160, June 1, 2007. doi: 10.1158/1055-9965.EPI-07-0089
© 2007 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Soegaard, M.
Right arrow Articles by Kjaer, S. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Soegaard, M.
Right arrow Articles by Kjaer, S. K.

Different Risk Factor Profiles for Mucinous and Nonmucinous Ovarian Cancer: Results from the Danish MALOVA Study

Marie Soegaard1, Allan Jensen1, Estrid Høgdall1, Lise Christensen2, Claus Høgdall3, Jan Blaakær4 and Susanne K. Kjaer1,3

1 Institute of Cancer Epidemiology, Danish Cancer Society; 2 Department of Pathology, Bispebjerg Hospital; 3 The Gynaecologic Clinic, The Juliane Marie Centre, Rigshospitalet, Copenhagen, Denmark; and 4 Department of Gynaecology and Obstetrics, Aarhus University Hospital, Skejby, Aarhus, Denmark

Requests for reprints: Susanne Krüger Kjaer, Institute of Cancer Epidemiology, Danish Cancer Society/Rigshospitalet, Strandboulevarden 49, DK-2100 Copenhagen, Denmark. Phone: 45-3525-7663. E-mail: susanne{at}cancer.dk.

Objectives: The aim of the study was to examine the overall risk factors for epithelial ovarian cancer and according to histologic subtypes.

Materials and Methods: Ovarian cancer cases and controls were recruited from 1995 to 1999, and personal interviews were conducted. A total of 554 cases and 1,564 randomly selected controls were included. The analyses were done using multiple logistic regression models.

Results: The overall risk of ovarian cancer decreased with ever being pregnant [odds ratios (OR), 0.40; 95% confidence intervals (CI), 0.30-0.55], with increasing pregnancies (OR, 0.63; 95% CI, 0.45-0.87 and OR, 0.51; 95% CI, 0.37-0.69 for two and three pregnancies as compared with one), and with older age at first and last pregnancy, respectively. Increasing years of ovulation was a very strong risk factor with a 7% to 8% increase in risk for each year of ovulation. Use of oral contraceptives (OR, 0.67, 95% CI, 0.53-0.85) and longer duration of use were associated with a decreased risk of ovarian cancer. Ever use of hormone replacement therapy increased the overall risk (OR, 1.30; 95% CI, 1.05-1.61). For all those variables, the effect was present for serous tumors, endometrioid tumors, and tumors of other histologies, but not for mucinous tumors. In contrast, current smoking was a risk factor only for mucinous tumors (OR, 1.78; 95% CI, 1.01-3.15) and increasing body mass index tended to increase the risk especially for mucinous and endometrioid tumors.

Conclusions: We confirmed already known risk factors for ovarian cancer, and we observed significant differences in the risk profiles between mucinous and nonmucinous tumors indicating different etiologies. (Cancer Epidemiol Biomarkers Prev 2007;16(6):1160–6)




This article has been cited by other articles:


Home page
Cancer Res.Home page
J. M. Schildkraut, E. L. Goode, M. A. Clyde, E. S. Iversen, P. G. Moorman, A. Berchuck, J. R. Marks, J. Lissowska, L. Brinton, B. Peplonska, et al.
Single Nucleotide Polymorphisms in the TP53 Region and Susceptibility to Invasive Epithelial Ovarian Cancer
Cancer Res., March 15, 2009; 69(6): 2349 - 2357.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
A. Jensen, H. Sharif, K. Frederiksen, and S. K. Kjaer
Use of fertility drugs and risk of ovarian cancer: Danish population based cohort study
BMJ, February 5, 2009; 338(feb05_2): b249 - b249.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
R. T. Palmieri, M. A. Wilson, E. S. Iversen, M. A. Clyde, B. Calingaert, P. G. Moorman, C. Poole, A. R. Anderson, S. Anderson, H. Anton-Culver, et al.
Polymorphism in the IL18 Gene and Epithelial Ovarian Cancer in Non-Hispanic White Women
Cancer Epidemiol. Biomarkers Prev., December 1, 2008; 17(12): 3567 - 3572.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
H. A. Risch
Cyclin E Overexpression Relates to Ovarian Cancer Histology but not to Risk Factors
Cancer Epidemiol. Biomarkers Prev., July 1, 2008; 17(7): 1841 - 1841.
[Full Text] [PDF]


Home page
Am J EpidemiolHome page
A. Jensen, H. Sharif, J. H. Olsen, and S. K. Kjaer
Risk of Breast Cancer and Gynecologic Cancers in a Large Population of Nearly 50,000 Infertile Danish Women
Am. J. Epidemiol., July 1, 2008; 168(1): 49 - 57.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2007 by the American Association for Cancer Research.